Lian et al. reported that C3 released from astrocytes interacts with C3aR on microglia and mediates Aβ pathology and neuroinflammation in AD, and these pathological features were ameliorated following treatment with a C3aR antagonist [45]. Here, C3AR1 is linked to Alzheimer disease.